Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first ta ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

Revolo completes patient enrollment in phase 2 trial of ‘1104 in eosinophilic esophagitis: New Orleans Wednesday, September 14, 2022, 14:30 Hrs [IST] Revolo Biotherapeutics (Rev ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...

Food impaction can occur in people who have eosinophilic esophagitis (EoE). Find out what to do in this urgent situation.

ON THIS PAGEWhy EoE and Asthma Are LinkedHow to Manage EoE and AsthmaAt first glance, eosinophilic esophagitis (EoE) and asthma may seem like two very different conditions. The former causes ...

If you have eosinophilic esophagitis (EoE), you may also have allergies, in the form of allergic rhinitis or food allergies. That’s not a coincidence. The two (or even three) conditions often coexist.

Introduction Patient Public Involvement (PPI) can enhance research impact; however, it is often poorly described, with a focus on study development. Here we describe an additional utility of PPI in ...

Background: Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease of the esophagus that affects both children and adults. Objective: The purpose of this article is to ...

Please provide your email address to receive an email when new articles are posted on . Eosinophilic esophagitis (EoE) in pediatric patients presents unique diagnostic and treatment challenges, often ...